The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using GLP-1Rs such as Ozempic or Wegovy.

The Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes accessibility, respect, and efficiency. In contrast to the often complex ...

Unlike semaglutide or liraglutide that only activate the GLP-1 receptor, the dual agonist tirzepatide works on the GLP-1 and GIP receptors, two important hormone pathways that help control hunger.

A fire erupted just north of the Stanwood exit off Old Highway 99, resulting in the total loss of several recreational vehicles and a shop structure.

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.

According to the MHRA, almost 400 people in the country have reported acute pancreatitis after they started taking semaglutide, liraglutide, or tirzepatide (the latest approved GLP-1 drug).

1. 7 million patients reveal stunning link between semaglutide and lower dementia risk Date: June 25, 2025 Source: Case Western Reserve University Summary: A blockbuster diabetes and weight-loss ...

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.

BELMONT, Calif., June 24, 2025 /PRNewswire/ -- Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its ...